ColoHealth Blood Test Offers a Simpler First Step in Colorectal Cancer Screening
New Day Diagnostics has launched ColoHealth, a physician-mediated blood test for colorectal cancer screening.
Category: Colorectal
Colorectal
Latest
Colorectal
Latest
Colorectal Cancer Screening Getting a Non-Invasive Boost
Stool-based tests are promising alternatives to colonoscopy for colorectal cancer screening, addressing global accessibility challenges.
Colorectal
Latest
Mainz Biomed Announces FDA Breakthrough Device Designation Submission for CRC Test
Mainz Biomed has applied for FDA Breakthrough Device Designation for its advanced non-invasive colorectal cancer screening test.
Mainz Biomed to Present Results of Colorectal Cancer Screening Study
Mainz Biomed will present the findings of a study that evaluated its multimodal screening test for the detection of colorectal cancer.
Read More
FDA Approves Geneoscopy’s Multi-Target Stool RNA Colorectal Cancer Test
Geneoscopy received U.S. FDA approval for ColoSense, a noninvasive colorectal cancer screening test that uses RNA biomarkers.
Read More
Researchers Identify the Critical Gap in Colorectal Cancer Screening
A significant gap exists in ensuring timely follow-up with colonoscopy after a positive stool test, hindering the effectiveness of screening.
Read More
How Effective are Blood Tests for Colorectal Cancer Screening?
New studies are cautioning against the use of blood tests to replace established colorectal cancer screening tests.
Read More
Next-Gen Stool DNA Test for Colorectal Cancer Has High Detection Rate
Researchers say the test has the best performance for the detection of both colorectal cancer and advanced precancerous polyps.
Read More
Blood Test Shows High Accuracy for Colorectal Cancer Detection
The blood test is intended for screening colorectal cancer in people who are of average risk and not experiencing symptoms.
Read More
Preventive Blood Test for Colorectal Cancer Gets FDA Breakthrough Device Designation
The PreveCol test for cancer is aimed at the early detection of biomarkers in blood associated with colorectal neoplasia.
Read More
Guardant Gives Tentative Date of FDA Advisory Panel Review for Shield Blood Test
Guardant Health announced the FDA is scheduled to review the premarket approval application for the company’s colorectal cancer blood test.
Read More
How At-Home Colorectal Cancer Screenings Pose Challenges
Researchers found that about 10% of at-home screening tests for colorectal cancer tests could not be processed, mostly due to patient error.
Read More
DiaCarta Launches OTC at Home Fecal Occult Blood Test
DiaCarta has received US FDA 510(k) clearance for its over the counter (OTC) at home iColon Fecal Occult Blood Test (FOBT).
Read More
Universal DX Collaborates with Quest on Advanced Colorectal Cancer Blood Tests
Universal DX announced a strategic collaboration with Quest Diagnostics designed to improve colorectal cancer screening in the United States.
Read More
Strategic Collaboration Aims to Bring Advanced Colorectal Cancer Screening to U.S.
Universal DX has announced a strategic collaboration with Quest Diagnostics to improve colorectal cancer screening in the United States.
Read More
Geneoscopy and Labcorp Partner to Distribute Noninvasive Colorectal Cancer Test
Geneoscopy’s multi-target stool RNA (mt-sRNA) biomarker panel is designed to detect precancerous lesions and colorectal cancer.
Read More
AI Tool Outperforms Other Colorectal Cancer Analysis Methods
Researchers have developed an artificial intelligence (AI) tool for automatic colorectal cancer tissue analysis.Â
Read More
Liquid Biopsy May Guide Colon Cancer Adjuvant TreatmentÂ
Liquid biopsy may be used to improve the response to standard chemotherapy regimens in patients with stage III or stage II colon cancer.
Read More